Dren Bio: Dren Bio Raises $65M in Series B Financing

Dren Bio, a Foster City, CA-based clinical-stage biopharmaceutical company, raised $65M in Series B funding. The round was led by Aisling Capital and HBM Healthcare Investments, with participation from Pfizer, ArrowMark Partners, Revelation Partners, SR One, 8VC, Taiho Ventures, BVF Partners, Mission BioCapital and Alexandria Venture Investments, amongst others. In connection with the closing of [...] The post Dren Bio Raises $65M in Series B Financing appeared first on FinSMEs.